Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay J Mathew

Showing results (131-140 of 190) with videos related to

Pageof 19
Sort By:
Molecular Psychiatry|May 16, 2024
Improved implicit self-esteem is associated with extended antidepressant effects following a novel synergistic interventionH Nur Eken, Crystal Spotts, Benjamin Panny, et al.
Psychopharmacology|September 12, 2013
Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant responseJames W Murrough, Le-Ben Wan, Brian Iacoviello, et al.
The International Journal of Neuropsychopharmacology|August 22, 2022
A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic KetamineBartholt Bloomfield-Clagett, Elizabeth D Ballard, Deanna K Greenstein, et al.
CNS Spectrums|September 13, 2005
Synchronized maternal-infant elevations of primate CSF CRF concentrations in response to variable foraging demandJeremy D Coplan, Margaret Altemus, Sanjay J Mathew, et al.
Molecular Psychiatry|March 26, 2025
Effects of KCNQ potassium channel modulation on ventral tegmental area activity and connectivity in individuals with depression and anhedoniaLaurel S Morris, Sara Costi, Sara Hameed, et al.
Translational Psychiatry|May 10, 2023
Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depressionJared Kopelman, Timothy A Keller, Benjamin Panny, et al.
Psychophysiology|February 27, 2019
Psychophysiological treatment outcomes: Corticotropin-releasing factor type 1 receptor antagonist increases inhibition of fear-potentiated startle in PTSD patientsTanja Jovanovic, Erica J Duncan, Joanna Kaye, et al.
Biological Psychiatry|September 27, 2003
A magnetic resonance spectroscopic imaging study of adult nonhuman primates exposed to early-life stressorsSanjay J Mathew, Dikoma C Shungu, Xiangling Mao, et al.
The American Journal of Psychiatry|August 29, 2013
Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trialJames W Murrough, Dan V Iosifescu, Lee C Chang, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 24, 2023
Efficacy and safety of zuranolone co-initiated with an antidepressant in adults with major depressive disorder: results from the phase 3 CORAL studySagar V Parikh, Scott T Aaronson, Sanjay J Mathew, et al.
Pageof 19

Showing results (131-140 of 190) with videos related to

Sort By:
Pageof 19
Molecular Psychiatry|May 16, 2024
Improved implicit self-esteem is associated with extended antidepressant effects following a novel synergistic interventionH Nur Eken, Crystal Spotts, Benjamin Panny, et al.
Psychopharmacology|September 12, 2013
Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant responseJames W Murrough, Le-Ben Wan, Brian Iacoviello, et al.
The International Journal of Neuropsychopharmacology|August 22, 2022
A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic KetamineBartholt Bloomfield-Clagett, Elizabeth D Ballard, Deanna K Greenstein, et al.
CNS Spectrums|September 13, 2005
Synchronized maternal-infant elevations of primate CSF CRF concentrations in response to variable foraging demandJeremy D Coplan, Margaret Altemus, Sanjay J Mathew, et al.
Molecular Psychiatry|March 26, 2025
Effects of KCNQ potassium channel modulation on ventral tegmental area activity and connectivity in individuals with depression and anhedoniaLaurel S Morris, Sara Costi, Sara Hameed, et al.
Translational Psychiatry|May 10, 2023
Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depressionJared Kopelman, Timothy A Keller, Benjamin Panny, et al.
Psychophysiology|February 27, 2019
Psychophysiological treatment outcomes: Corticotropin-releasing factor type 1 receptor antagonist increases inhibition of fear-potentiated startle in PTSD patientsTanja Jovanovic, Erica J Duncan, Joanna Kaye, et al.
Biological Psychiatry|September 27, 2003
A magnetic resonance spectroscopic imaging study of adult nonhuman primates exposed to early-life stressorsSanjay J Mathew, Dikoma C Shungu, Xiangling Mao, et al.
The American Journal of Psychiatry|August 29, 2013
Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trialJames W Murrough, Dan V Iosifescu, Lee C Chang, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 24, 2023
Efficacy and safety of zuranolone co-initiated with an antidepressant in adults with major depressive disorder: results from the phase 3 CORAL studySagar V Parikh, Scott T Aaronson, Sanjay J Mathew, et al.
Pageof 19